Clinical Trial Update: A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 [Phase 3]

View source ↗

Summary

A Phase 3 trial of SPARC1507 in advanced biliary tract cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• SPARC1507

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Advanced Biliary Tract Cancer | Phase 3 | Status: WITHDRAWN